Psy­che­delic helps those with can­cer cope, 2 new stud­ies find

Baltimore Sun - - FRONT PAGE - By An­drea K. McDaniels

Re­searchers at the Johns Hop­kins School of Medicine have found that a psy­che­delic drug can sig­nif­i­cantly re­duce anx­i­ety, de­pres­sion and other emo­tional dis­tress in can­cer pa­tients.

The pa­tients ex­pe­ri­enced al­most im­me­di­ate re­lief, which lasted for months, after tak­ing psilo­cy­bin, the ac­tive hal­lu­cino­genic in­gre­di­ent in “magic mush­rooms,” the re­searchers re­ported. A sep­a­rate study by re­searchers at New York Uni­ver­sity’s Lan­gone Med­i­cal Cen­ter found the same ef­fect.

The find­ings are the lat­est in a grow­ing body of re­search on how psychedelics can be used to treat var­i­ous ill­nesses. Stud­ies in­volv­ing the drugs have resurged in re­cent years after be­ing stymied for decades when the fed­eral gov­ern­ment deemed psychedelics a danger­ous con­trolled sub­stance and stopped fund­ing the re­search.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.